(Q44339785)

2 December 2017

title

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy (English)

1 reference

2 December 2017

1 reference

M D Privitera

1

1 reference

2 December 2017

M J Brodie

2

1 reference

2 December 2017

R H Mattson

3

1 reference

2 December 2017

D W Chadwick

4

1 reference

2 December 2017

W Neto

5

1 reference

2 December 2017

S Wang

6

1 reference

2 December 2017

EPMN 105 Study Group

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Acta Neurologica Scandinavica

2 December 2017

published in

1 reference

2 December 2017

volume

107

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

165-175

1 reference

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

The National General Practice Study of Epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

A pilot study of topiramate in the treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Long-term response to topiramate in patients with West syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Topiramate monotherapy for partial onset seizures.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Some statistical methods for combining experimental results

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00093.X

7 January 2021

10.1034/J.1600-0404.2003.00093.X

Identifiers

DOI

1 reference

2 December 2017

1 reference